Hints and tips:
Related Special Reports
Related Topics
...While Anderson has warned the revamp will lead to “significant” job cuts, Bayer employees have been supportive....
...Bayer warned investors that ebitda would fall further this year to around €11bn....
...Much of Bayer’s debt is long-term but about €4.3bn of bonds mature this year. For now, Anderson is trying to fix Bayer organically....
...But even optimists would struggle with no direction at all on Bayer’s future structure....
...Bayer paid out a dividend of €2.40 for 2022....
...“The public debate about Bayer’s future was too narrowly focused on a break-up,” he said, adding that Anderson was right to address Bayer’s underlying problems....
...The Texas native, who joined Bayer last summer after his predecessor Werner Baumann was pushed out, argued that Bayer first needed to focus on fixing its financial and operating problems, warning that the...
...US trial attorneys are eager to keep fighting Bayer in court....
...to Bayer....
...Bayer paid a dividend of €2.40 for 2022. Analysts had expected Bayer to pay a dividend of €1.92 per share for 2023, a far more modest cut....
...A spokesman for Bayer said the company would appeal and that it disagrees with the jury’s adverse verdict....
...Bayer closed down nearly 8 per cent, putting its market cap below €26bn....
...Leverkusen, which is owned by chemicals company Bayer, is one of a handful of exceptions....
...Bayers shares plunged 18 per cent to €34, reaching lows not seen since 2008....
...“Bayer is running out of options strategically as well as financially.”...
...Bayer is under pressure from shareholders as it is reeling from the $63bn acquisition of US crop science giant Monsanto....
...that Roundup causes cancer, which Bayer denies....
...Bayer will give a detailed outlook for next year in March....
...Bayer last week abandoned a trial of blood-thinner asundexian after it did not work as hoped to treat heart disease....
...These patent expiries, declining farm incomes and a battery of legal claims — estimated at €9bn by Berenberg’s Sebastian Bray — weigh on Bayer shares....
...So what sort of legal strategy is Bayer considering now?...
...Mentioned in this podcast: Buffett sounds wildfire alarm as utilities industry enters new era Bayer slashes dividend by 95% as it steps up effort to cut debt Bayer’s struggling Roundup court strategy...
...Mentioned in this podcast: Bayer chief rules out capital increase as investors slam turnaround plan Is private equity actually worth it?...
...Big share price moves in Europe today include Swiss cement giant Holcim, German pharmaceuticals group Bayer, and Dutch conglomerate Philips....
...Corporate updates: German pharmaceutical company Bayer reports full-year results, alongside a strategy update from chief executive Bill Anderson, as the company faces numerous lawsuits in the US....
International Edition